RESUMEN
PURPOSE: Antibiotic locks in catheter-dependent chronic hemodialysis patients reduce the rate of catheter-related bloodstream infections (CRBSIs), but may be associated with the development of resistant bacteria. Ethanol-based catheter locks may provide a better alternative; however, there are limited data on the long-term integrity of dialysis catheters exposed to ethanol. METHODS: We performed in vitro testing of two types of hemodialysis catheterssilicone (SLC) and carbothane (CBT) basedwith a 70% ethanol lock (EL) versus heparin lock (HL) for 26 weeks. Lock solutions were changed thrice weekly to mimic a conventional hemodialysis schedule. We tested mechanical properties of the catheters at 0, 13 and 26 weeks by examining stress/strain relationships (SS400%) and modulus of elasticity (ME). Electron microscopy was performed to examine catheter ultrastructure at 0 and 26 weeks. RESULTS: Catheter integrity for HL versus EL in SLC (SS400%: 4.5 vs. 4.5 MPa, p = NS; ME: 4.6 vs. 4.7 MPa, p = NS) or CBT-based catheters (SS400%: 7.6 vs. 8.9 MPa, p = NS; ME: 9.6 vs. 12.2 MPa, p = NS) were all similar at 13 and 26 weeks. Scanning electron microscopy revealed no structural changes in the central and luminal wall internal surfaces of EL- versus HL-treated catheters. CONCLUSIONS: There were no significant differences in catheter integrity between SLC or CBT catheters exposed to a 70% EL for 26 weeks. Given its low cost, potential to avoid antibiotic resistance and structural integrity after 6 months of high-dose ethanol, ELs should be studied prospectively against antibiotic locks to assess the efficacy and safety in hemodialysis patients.
Asunto(s)
Antiinfecciosos Locales/química , Catéteres de Permanencia , Etanol/química , Diálisis Renal/instrumentación , Siliconas/química , Dispositivos de Acceso Vascular , Antibacterianos/uso terapéutico , Antiinfecciosos Locales/uso terapéutico , Anticoagulantes/química , Infecciones Relacionadas con Catéteres/microbiología , Infecciones Relacionadas con Catéteres/prevención & control , Catéteres de Permanencia/efectos adversos , Módulo de Elasticidad , Análisis de Falla de Equipo , Etanol/uso terapéutico , Heparina/química , Ensayo de Materiales , Diseño de Prótesis , Falla de Prótesis , Diálisis Renal/efectos adversos , Estrés Mecánico , Factores de Tiempo , Dispositivos de Acceso Vascular/efectos adversosAsunto(s)
Nefritis Intersticial , Analgésicos/efectos adversos , Antiinfecciosos/efectos adversos , Humanos , Litio/efectos adversos , Metales Pesados/efectos adversos , Mieloma Múltiple/complicaciones , Nefritis Intersticial/clasificación , Nefritis Intersticial/etiología , Nefritis Intersticial/patología , Nefritis Intersticial/fisiopatología , Nefritis Intersticial/terapia , Sarcoidosis/complicaciones , Enfermedades Urológicas/complicacionesRESUMEN
BACKGROUND: The renal effects of cyclooxygenase-2 (COX-2) inhibitors have been incompletely elucidated, and acute renal failure (ARF) due to COX-2 inhibitors has been reported. METHODS: In order to determine the causes of ARF and hyperkalaemia in five patients during COX-2 inhibitor therapy, we carefully analysed case studies of consecutive in-patients or out-patients referred to our Renal Division over a 6-month period for ARF and hyperkalaemia who had recently received COX-2 inhibitors. RESULTS: ARF developed 2-3 weeks after COX-2 inhibitor therapy in five patients. The ARF was consistent with pre-renal azotaemia from renal hypoperfusion. Four patients were receiving the loop diuretic, furosemide. Four patients developed hyperkalaemia and decreased serum bicarbonate despite diuretic therapy, and one patient had changes in plasma renin activity and aldosterone levels consistent with reversible hyporeninaemic hypoaldosteronism. Renal failure was reversible after discontinuation of diuretics and COX-2 inhibitors. CONCLUSIONS: COX-2 inhibitors may cause reversible ARF and hyperkalaemia in patients with oedematous conditions treated with low sodium diets and loop diuretics.